Online citations, reference lists, and bibliographies.
← Back to Search

In Vitro And In Vivo Evaluation Of Functionalized Chitosan-Pluronic Micelles Loaded With Myricetin On Glioblastoma Cancer.

G. Wang, J. Wang, Xiangjun Tang, L. Du, F. Li
Published 2016 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This study aimed to develop a novel polymeric carrier based on chitosan-functionalized Pluronic P123/F68 micelles loaded with myricetin (MYR) to improve the therapeutic index of chemotherapy for glioblastoma cancer. Following characterization and assessment of the cellular uptake and antitumor effects of MYR-loaded micelles (MYR-MCs) in vitro, the acute toxicity, blood-brain barrier (BBB) translocation, brain uptake and biodistribution in vivo were assessed. The results demonstrated that MYR-MCs exhibited improved cellular uptake and antitumor activity compared to free MYR in vitro, with a significantly enhanced anticancer effect in vivo following efficient transport across the BBB. However, MYR-MCs did not affect the brain endothelial, barrier function, the liver, heart or kidneys. Furthermore, MYR-MCs altered the expression of apoptotic proteins, such as Bcl-2, BAD and BAX, in mice. In conclusion, MYR-MCs may be considered an effective and promising drug delivery system for glioblastoma treatment.
This paper references
10.1002/BDD.325
Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery
J. Cory Kalvass (2002)
10.1016/j.colsurfb.2012.08.062
Nano-formulation of paclitaxel by vitamin E succinate functionalized pluronic micelles for enhanced encapsulation, stability and cytotoxicity.
Youhua Tao (2013)
10.2217/CNS.12.42
Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.
R. Kanai (2013)
10.2353/AJPATH.2007.070011
Genetic pathways to primary and secondary glioblastoma.
H. Ohgaki (2007)
10.1016/S0006-2952(97)82453-7
Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition.
G. Agulló (1997)
10.1016/j.jconrel.2010.06.018
Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Kun Shao (2010)
10.1016/j.canlet.2009.04.002
Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2.
M. Siegelin (2009)
10.1124/DMD.104.001222
RELATIONSHIP BETWEEN EXPOSURE AND NONSPECIFIC BINDING OF THIRTY-THREE CENTRAL NERVOUS SYSTEM DRUGS IN MICE
T. Maurer (2005)
10.1677/JOE-07-0097
Phosphoinositide 3-kinases as a common platform for multi-hormone signaling.
E. Hirsch (2007)
10.1016/S0163-7258(03)00014-7
Current and future strategies for the treatment of malignant brain tumors.
M. Castro (2003)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
10.1016/j.nec.2012.04.006
Nanotechnology applications for glioblastoma.
Edjah K. Nduom (2012)
Preformulation studies of myricetin: a natural antioxidant flavonoid.
Yashu Yao (2014)
10.1016/S0142-9612(03)00348-X
Surface-engineered nanoparticles for multiple ligand coupling.
R. Gref (2003)
10.1001/jamaoto.2013.214
Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma.
S. Cohen (2013)
10.1016/j.jconrel.2009.08.014
In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
E. Lee (2009)
10.3109/1061186X.2014.913052
Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating
Jiangxiu Niu (2014)
10.1016/j.jconrel.2012.04.034
Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes.
Rita Nieto Montesinos (2012)
10.1007/s10555-012-9347-y
Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities
Chia-Jui Weng (2012)
10.1016/j.colsurfb.2013.07.031
Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
V. Saxena (2013)
10.1016/j.ijpharm.2010.06.021
New self-assembling polyaspartylhydrazide copolymer micelles for anticancer drug delivery.
M. Licciardi (2010)
10.1016/j.nbd.2009.09.015
Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE2 activation
W. Chiu (2010)
10.1007/PL00000584
Human enzymatic activities related to the therapeutic administration of chitin derivatives
R. Muzzarelli (1997)
10.1016/j.bbcan.2012.05.004
Glioblastoma: therapeutic challenges, what lies ahead.
Flavia R.S. Lima (2012)
10.1016/J.BIOMATERIALS.2006.11.013
Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.
Shao-qiong Liu (2007)
10.1016/j.ejpb.2012.09.014
Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
Z. Wei (2013)
10.18433/J3JC7C
Chitosan mediated targeted drug delivery system: a review.
M. P. Patel (2010)
10.1016/j.ijpharm.2009.04.030
Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
Z. Wei (2009)
10.1016/j.biomaterials.2009.09.104
Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
Z. Wang (2010)
10.1111/epi.12318
Expression and functional relevance of UGT1A4 in a cohort of human drug‐resistant epileptic brains
C. Ghosh (2013)
10.1016/j.ijpharm.2013.01.050
Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.
J. Seguin (2013)
10.1016/j.neuroscience.2011.03.064
Mechanisms underlying the protective effects of myricetin and quercetin following oxygen-glucose deprivation-induced cell swelling and the reduction in glutamate uptake in glial cells
K. Panickar (2011)
10.1016/j.ijpharm.2010.03.001
Preparation of tri-block copolymer micelles loading novel organoselenium anticancer drug BBSKE and study of tissue distribution of copolymer micelles by imaging in vivo method.
M. Liu (2010)
10.1016/j.jconrel.2010.02.024
Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy.
Kyung Hyun Min (2010)



This paper is referenced by
10.1016/j.ijpharm.2020.119544
Targeting Anticancer Drugs with Pluronic Aggregates: Recent Updates.
Sanjay Tiwari (2020)
10.3389/fneur.2020.00740
Chitosan-Based Non-viral Gene and Drug Delivery Systems for Brain Cancer
Montserrat Lara-Velazquez (2020)
10.1016/j.carbpol.2017.10.030
1, 3β-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy.
P. Singh (2018)
10.1016/j.ijbiomac.2019.07.168
Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers.
T. Dou (2019)
10.1016/j.ijbiomac.2017.01.036
Highly biocompatible chitosan with super paramagnetic calcium ferrite (CaFe2O4) nanoparticle for the release of ampicillin.
R. Bilas (2017)
10.2174/2405461503666181119103142
Role of Nanomedicine in Treatment of Brain Cancer
S. Verma (2020)
10.2147/IJN.S218944
Investigation Of Vitamin B12-Modified Amphiphilic Sodium Alginate Derivatives For Enhancing The Oral Delivery Efficacy Of Peptide Drugs
Lingli Long (2019)
10.1186/s12645-020-00059-3
Preferential drug delivery to tumor cells than normal cells using a tunable niosome–chitosan double package nanodelivery system: a novel in vitro model
M. Wiranowska (2020)
10.1080/1061186X.2017.1289538
Recent progress in drug delivery of pluronic P123: pharmaceutical perspectives
Liyan Zhao (2017)
10.3389/fbioe.2019.00341
The Extracellular Matrix and Biocompatible Materials in Glioblastoma Treatment
A. Belousov (2019)
10.1007/s10989-019-09895-3
Myricetin Loaded Solid Lipid Nanoparticles Upregulate MLKL and RIPK3 in Human Lung Adenocarcinoma
L. Khorsandi (2019)
10.1016/j.addr.2019.01.012
A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders.
J. Samal (2019)
10.3390/membranes10090212
A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
H. Cortés (2020)
10.1007/s13205-020-02207-3
A review on myricetin as a potential therapeutic candidate for cancer prevention
Nazia Afroze (2020)
10.2174/1381612822666161027111542
Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS.
M. Gagliardi (2017)
10.2741/4771
Nano-engineered flavonoids for cancer protection.
N. Bunkar (2019)
10.1007/s40263-016-0405-9
Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain
M. Patel (2017)
10.1016/j.carbpol.2018.09.065
N,N,N-trimethyl chitosan embedded in situ Pluronic F127 hydrogel for the treatment of brain tumor.
Md Hasan Turabee (2019)
10.1016/j.biopha.2019.109506
Anti-tumor effects and associated molecular mechanisms of myricetin.
Min Jiang (2019)
10.1186/s12951-017-0251-z
Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy
J. Wang (2017)
10.3390/molecules23102661
Chitosan-Based Nanomaterials for Drug Delivery
Jianghua Li (2018)
10.1016/j.trecan.2018.11.002
Glioblastoma Therapy in the Age of Molecular Medicine.
L. Geraldo (2019)
10.1080/21691401.2018.1489825
Myricetin nanoliposomes induced SIRT3-mediated glycolytic metabolism leading to glioblastoma cell death
G. Wang (2018)
10.4155/TDE-2016-0051
Novel biodegradable nanocarriers for enhanced drug delivery.
M. Gagliardi (2016)
10.3390/pharmaceutics12111013
Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers
Anna E Caprifico (2020)
10.1002/jcp.27628
Leukemia therapy by flavonoids: Future and involved mechanisms
R. Saraei (2019)
10.1002/MACP.201600234
Acid-Labile Copolymer Micelles Cross-Linked by a Twin Ortho Ester Cross-Linking Agent: Synthesis, Characterization, and Evaluation
X. Wang (2016)
10.1016/j.biochi.2019.04.023
Flavonoid loaded nanoparticles as an effective measure to combat oxidative stress in Ribonuclease A.
P. Roy (2019)
10.1016/j.jconrel.2017.06.019
Self‐assembled amphiphilic core‐shell nanocarriers in line with the modern strategies for brain delivery
Reham S. Elezaby (2017)
10.2147/IJN.S114302
Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
Xiangjun Tang (2016)
10.1021/acs.molpharmaceut.6b01068
Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
Yanzuo Chen (2017)
10.1016/j.biopha.2019.109561
Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Y. Song (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar